Brucellosis at the dawn of the 21st century;La brucellose à l'aube du 21e siècle

Medecine et Maladies Infectieuses

Volumn 35, Issue 1, 2005, Pages 6-16

  Maurin, M ^a  

^a UNIV GRENOBLE ALPES   (France)

Author keywords

Brucellose; Brucellosis; Zoonose; Zoonosis

Indexed keywords

AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; BRUCELLA VACCINE; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; IMIPENEM; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM;

BRUCELLOSIS; HUMAN; NONHUMAN; REVIEW;

EID: 13244254210     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.medmal.2004.08.003     Document Type: Short Survey

References (100)

1. P.S.A. Sarinas, and R.K. Chitkara Brucellosis Sem Resp. Infect. 18 2003 168 182
2. D.R. Ewalt, J.B. Payeur, M.B. Martin, D.R. Cummins, and W.G. Miller Characteristics of a Brucella species from a bottlenose dolphin (Tursiops truncatus) J. Vet. Diagn. Investig. 6 1994 448 452
3. B.J. Bricker, D.R. Ewalt, A.P. MacMillan, G. Foster, and S. Brew Molecular characterization of Brucella strains isolated from marine mammals J. Clin. Microbiol. 38 2000 1258 1262
4. A.H. Sohn, W.S. Probert, C.A. Glaser, N. Gupta, A.W. Bollen, and J.D. Wong Human neurobrucellosis with intracerebral granuloma caused by a marine mammal Brucella spp Emerg. Infect. Dis. 9 2003 485 488
5. M.R. Hilleman Overview:: cause and prevention in biowarfare and bioterrorism Vaccine 20 2002 3055 3067
6. W.F. Klietmann, and K.L. Ruoff Bioterrorism: implications for the clinical microbiologist Clin. Microbiol. Rev. 14 2001 364 381
7. E. Moreno, E. Stackebrant, M. Dorsch, J. Wolters, M. Busch, and H. Mayer Brucella abortus 16SrRNA and lipid A reveal a phylogenetic relationship with members of the alpha-2 subdivision of the class Proteobacteria J. Bacteriol. 172 1990 3569 3576
8. M. Yanagi, and K. Yamasato Phylogenetic analysis of the family Rhizobiaceae and related bacteria by sequencing of 16S rRNA gene using PCR and DNA sequencer FEMS Microbiol. Lett. 107 1993 115 120
9. K.L. Jahans, G. Foster, and E.S. Broughton The characterisation of Brucella strains isolated from marine mammals Vet Microbiol. 57 1997 373 382
10. A. Cloeckaert, J.M. Verger, M. Grayon, J.Y. Paquet, B. Garin-Bastuji, and G. Foster Classification of Brucella spp. isolated from marine mammals: polymorphism at the omp2 locus Microbes Infect. 3 2001 729 738
11. A. Cloeckaert, M. Grayon, O. Grepinet, and K.S. Boumedine Classification of Brucella strains isolated from marine mammals: infrequent restriction site-PCR and development of specific PCR identification tests Microbes Infect. 5 2003 593 602
12. J.M. Verger, F. Grimont, P.A.D. Grimont, and M. Grayon Brucella, a monospecific genus as shown by deoxyribonucleic acid hybridization Int. J. Syst. Bacteriol. 35 1985 292 295
13. M. Verger, M. Grayon, A. Cloeckaert, M. Lef̀vre, E. Ageron, and F. Grimon Classification of Brucella strain isolated from marine mammals using DNA-DNA hybridization and ribotyping Res. Microbiol. 151 2000 797 799
14. B. Gandara, A. Lopez Merino, M. Antonio Rogel, and E. Martinez-Romero Limited genetic diversity of Brucella spp J. Clin. Microbiol. 39 2001 235 240
15. D.S. Shapiro, and J.D. Wong Brucella P.R. Murray E.J. Baron M.A. Pfaller F.C. Tenover R.H. Yolken Manual of Clinical Microbiology 1999 American Society for Microbiolgy Washington DC 625 631
16. P. Yagupsky Detection of Brucellae in blood cultures J. Clin. Microbiol. 37 1999 3437 3442
17. S. Robichaud, M. Libman, M. Behr, and E. Rubin Prevention of laboratory-acquired brucellosis Clin. Infect. Dis. 38 2004 119 122
18. E. Freer, N. Rojas, A. Weintraub, A.A. Lindberg, and E. Moreno Heterogeneity of Brucella abortus lipopolysaccharides Res. Microbiol. 146 1995 569 578
19. J. Ko, and G.A. Splitter Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans Clin. Microbiol. Rev. 16 2003 65 78
20. S. Michaux-Charachon, V. Foulongne, D. O'Callagnan, and M. Ramuz Brucella ̀ l'aube du troisìme milĺnaire:: organisation du ǵnome et pouvoir pathog̀ne Pathol. Biol. 50 2002 401 412
21. A. Cloackaert, A. Tibor, and M.S. Zygmunt Brucella outer membrane lipoproteins share antigenic determinants with bacteria of the family Rhizobiaceae Clin. Diagn. Lab. Immunol. 6 1999 627 629
22. V.G. DelVecchio, V. Kapatral, R.J. Redkar, G. Patra, C. Mujer, and T. Los The genome sequence of the facultative intracellular pathogen Brucella melitensis Proc. Natl. Acad. Sci. U.S.A 99 2002 443 448
23. S. Michaux, J. Paillisson, M.J. Carles-Nurit, G. Bourg, A. Allardet-Servent, and M. Ramuz Presence of two independant chromosomes in the Brucella melitensis genome J. Bacteriol. 175 1993 701 705
24. E. Jumas-Bilak, S. Michaux-Charachon, G. Bourg, D. O'Callaghan, and M. Ramuz Diff́rences in chromosome number and genome rearrangements in the genus Brucella Mol. Microbiol. 27 1998 99 106
25. I. Paulsen, R. Seshadri, K.E. Nelson, J.A. Eisen, J.F. Heidelberg, and T.D. Read The Brucella suis genome reveals fundamental similarities between animal and plant pathogens and symbionts Proc. Natl. Acad. Sci. USA 99 2002 13148 13153
26. M.J. Corbel Brucellosis:: an overview Emerg. Infect. Dis. 3 1997 213 221
27. E.J. Young An overview of human brucellosis Clin. Infect. Dis. 21 1995 283 290
28. Garin-Bastuji B, Delcueillerie F. Les brucelloses humaine et animale en France en l'an 2000. Situation épidémiologique - Programmes de contrôle et d'éradication. Med Mal Infect 2001; 31 suppl 2: 202-216.
29. Durr U, Valenciano M, Vaillant V. La brucellose humaine en France de 1998 ̀ 2000. Surveillance Nationale des maladies infectieuses. Institut de Veille Sanitaire. Rapport 1998-2000. 2003.
30. J. Godfroid, and A. Käsbohrer Brucellosis in the European Union and Norway at the turn of the twenty-first century Vet. Microbiol. 90 2002 135 145
31. J. Godfroid Brucellosis in wildlife Rev. Sci. Tech. Off Epiz 21 2002 277 286
32. B. Ruben, J.D. Band, P. Wong, and J. Colville Person-to-person transmission of Brucella melitensis Lancet 1 1991 14 15
33. J.F. Sadusk, A.S. Browne, and J.L. Born Brucellosis in man, resulting from Brucella abortus (strain 19) vaccine JAMA 164 1957 1325 1328
34. E.J. Young Human brucellosis Rev. Infect. Dis. 5 1983 821 842
35. Centers for Disease Control and Prevention Human exposure to Brucella abortus strain RB51, Kansas, 1997 MMWR 47 1998 172 175
36. A. Gross, A. Terraza, S. Ouahrani-Bettache, J.P. Liautard, and J. Dornand In vitro Brucella suis infection prevents the programmed cell death of human monocytic cells Infect. Immun. 68 2000 342 351
37. D. O'Callaghan, C. Cazevieille, A. Allardet-Servent, M.L. Boschiroli, G. Bourg, and V. Foulongne A homologue of the Agrobacterium tumefaciens VirB and Bordetella pertussis Ptl type IV secretion systems is essential for intracellular survival of Brucella suis Mol. Microbiol. 33 1999 1210 1220
38. P.C. Hong, R.M. Tsolis, and T.A. Ficht Identification of genes required for chonic persistence of Brucella abortus in mice Infect. Immun. 68 2000 4102 4107
39. M.L. Boschiroli, S. Ouahrani-Bettache, V. Foulongne, S. Michaux-Charachon, G. Bourg, and A. Allardet-Servent The Brucella suis virB operon is induced intracellularly in macrophages Proc. Natl. Acad. Sci. USA 99 2001 1544 1549
40. J.D. Colmenero, J.M. Reguera, F. Martos, D. Sanchez De Mora, M. Delgado, and M. Causse Complications associated with Brucella melitensis infection: a study of 530 cases Medicine 75 1996 195 210
41. J. Solera, E. Lozano, E. Martinez-Alfaro, A. Espinosa, M.L. Castillejos, and L. Abad Brucellar spondylitis: review of 35 cases and literature survey Clin. Infect. Dis. 29 1999 1440 1449
42. J.M. Reguera, A. Alarcon, F. Miralles, J. Pachon, C. Juarez, and J.D. Colmenero Brucella endocarditis: clinical, diagnostic, and therapeutic approach Eur. J. Microbiol. Infect. Dis. 22 2003 647 650
43. H. Akdeniz, H. Irmak, O. Anlar, and A.P. Demiroz Central nervous system brucellosis: presentation, diagnosis and treatment J. Infect. 36 1998 297 301
44. J. Ariza, C. Pigrau, C. Canas, A. Marron, F. Martinez, and B. Almirante Current understanding and management of chronic hepatosplenic suppurative brucellosis Clin. Infect. Dis. 32 2001 1024 1033
45. M.Y. Khan, M.W. Mah, and Z.A. Memish Brucellosis in pregnant women Clin. Infect. Dis. 32 2001 1172 1177
46. S. Moreno, J. Ariza, F.J. Espinosa, D. Podzamczer, J.M. Miro, and A. Rivero Brucellosis in patients infected with the human immunodeficiency virus Eur. J. Clin. Micrbiol. Infect. Dis. J. 17 1998 319 326
47. F.A. Goldbaum, C.P. Rubbi, J.C. Wallach, S.E. Miguel, P.C. Baldi, and C.A. Fossati Differentiation between active and inactive human brucellosis by measuring atiprotein humoral immune responses J. Clin. Microbiol. 30 1992 604 607
48. P.C. Baldi, G.F. Araj, G.C. Racaro, J.C. Wallach, and C.A. Fossati Detection of antibodies to Brucella cytoplasmic proteins in the cerebrospinal fluid of patients with neurobrucellosis Clin. Diagn. Labo. Immunol. 6 1999 756 759
49. M. Drancourt, P. Brouqui, and D. Raoult Afipia clevelandensis antibodies and cross-reactivity with Brucella spp. and Yersinia enterocolitica O:9 Clin. Diagn. Lab. Immunol. 4 1997 748 752
50. C. Schoerner, K. Wartenberg, and M. Rollinghoff Differentiation of serological responses to Yersinia enterocolitica serotype O9 and Brucella species by immunoblot or enzyme-linked immunosorbent assay using whole bacteria and Yersinia outer memebrane proteins J. Clin. Microbiol. 28 1990 1570 1574
51. J. Erdenebaatar, B. Bayarsaikhan, M. Watarai, S.-I. Makino, and T. Shirahata Enzyme-linked immunosorbent assay to differentiate the antibody responses of animals infected with Brucella species from those of animals infected with Yersinia enterocolitica O9 Clin. Diagn. Lab. Immunol. 10 2003 710 714
52. A.M. Sifuentes-Rincon, A. Revol, and H.A. Barrera-Saldana Detection and differentiation of the six Brucella species by polymerase chain reaction Mol. Med. 3 1997 734 739
53. M.I. Queipo-Ortuno, P. Morata, P. Ocon, P. Manchado, and J.D. Colmenero Rapid diagnosis of human brucellosis by peripheral-blood PCR assay J. Clin. Microbiol. 35 1997 2927 2930
54. L. Zerva, K. Bourantans, S. Mitka, A. Kansouzidou, and N.J. Legakis Serum is the peferred clinical specimen for diagnosis of human brucellosis by PCR J. Clin. Microbiol. 39 2001 1661 1664
55. M.C. Casanas, M.I. Queipo-Ortuno, A. Rodriguez-Torres, A. Orduna, J.D. Colmenero, and P. Morata Specificity of a polymerase chain reaction assay of a target sequence on the 31-kilodalton Brucella antigen DNA used to diagnose human brucellosis Eur. J. Clin. Microbiol. Infect. Dis. 20 2001 127 131
56. P. Morata, M.I. Queipo-Ortuno, J.M. Reguera, F. Miralles, J.J. Lopez-Gonzalez, and J.D. Colmenero Diagnostic yield of a PCR assay in focal complications of brucellosis J. Clin. Microbiol. 39 2001 3743 3746
57. G.M. Matar, I.A. Khneisser, and A.M. Abdelnoor Rapid laboratory confirmation of human brucellosis by PCR analysis of a target sequence on the 31-kilodalton Brucella antigen DNA J. Clin. Microbiol. 34 1996 477 478
58. P. Morata, M.I. Queipo-Ortuno, and J.D. Colmenero Strategy for optimizing DNA amplification in a peripheral blood PCR assay used for diagnosis f human brucellosis J. Clin. Microbiol. 36 1998 2443 2446
59. P. Morata, M.I. Queipo-Ortuno, J.M. Reguera, M.A. Garcia-Ordonez, A. Cardenas, and J.D. Colmenero Development and evaluation of a PCR-enzyme linked immunosorbent assay for diagnosis of human brucellosis J. Clin. Microbiol. 41 2003 144 148
60. P. Morata, M.I. Queipo-Ortuno, J.M. Reguera, F. Miralles, J.J. Lopez-Gonzales, and J.D. Colmenero Diagnostic yield of a PCR assay in focal complications of brucellosis J. Clin. Microbiol. 39 2001 3743 3746
61. D.T. Newby, T.L. Hadfield, and F.F. Roberto Real-time PCR detection of Brucella abortus: a comparative study of SYBR green I, 5'-exonuclease, and hybridization probe assays Applied Envir. Microbiol. 69 2003 4753 4759
62. R. Redkar, S. Rosa, B. Bricker, and V. DelVecchio Real-time detection of Brucella abortus, Brucella melitensis and Brucella suis Mol. Cell. Probes. 15 2001 43 52
63. B.J. Bricker, and S.M. Halling Differentiation of Brucella abortus bv. 1, 2, and 4, Brucella melitensis, Brucella ovis, and Brucella suis bv. 1 by PCR J. Clin. Microbiol. 32 1994 2660 2666
64. T. Bogdanovich, M. Skurnik, P.S. Lübeck, P. Ahrens, and J. Hoorfar Validated 5' nuclease PCR assay for rapid identification of the genus Brucella J. Clin. Microbiol. 42 2004 2261 2263
65. A. Allardet-Servent, G. Bourg, M. Ramuz, M. Pages, M. Bellis, and G. Roizes DNA polymorphism in strains of the genus Brucella J. Bacteriol. 170 1988 4603 4607
66. B.J. Bricker, D.R. Ewalt, and S.M. Halling Brucella «HOOF prints»: strain typing by multi-locus analysis of variable number tandem repeats (VNTR) BMC Microbiology 3 2003 15 28
67. A. Cloeckaert, M. Grayon, and O. Grepinet An IS711 element downstream of the bp26 gene os a specific marker of Brucella spp. isolated from marine mammals Clin. Diagn. Lab. Immunol. 7 2000 835 839
68. W.H. Hall Modern chemotherapy for brucellosis in humans Rev. Infect. Dis. 12 1990 1060 1099
69. E. Rubinstein, R. Lang, B. Shasha, B. Hagar, L. Diamanstein, and G. Joseph In vitro susceptibility of Brucella melitensis to antibiotics Antimicrob. Agents Chemother. 35 1991 1925 1927
70. J. Bosch, J. Linares, M.J. Lopez de Goicoechea, J. Ariza, M.C. Cisnal, and R. Martin In vitro activity of ciprofloxacin, ceftriaxone, and five other antimicrobial agents against 95 strains of Brucella melitensis J. Antimicrob. Chemother. 17 1986 459 461
71. A. Gutierrez Altes, M. Diez Enciso, P. Pena Gracia, and A. Campos Bueno In vitro activity of N-formimidoyl thienamycin against 98 clinical isolates of Brucella melitensis compared with those of cefoxitine, rifampin, tetracycline, and co-trimoxazole Antimicrob. Agents Chemother. 21 1982 501 503
72. R. Landinez, J. Linarez, E. Loza, J. Martinez-Beltran, R. Martin, and F. Baquero In vitro activity of azithromycin and tetracycline against 358 clinical isolates of Brucella melitensis Eur. J. Clin. Microbiol. Infect. Dis. 11 1992 265 267
73. S.M. Qadri, M.A. Halim, Y. Ueno, F.M. Abumustafa, and A.G. Postle Antibacterial activity of azithromycin against Brucella melitensis Chemotherapy 41 1995 253 256
74. Trujillano-Martin I, Garcia-Sanchez E, Montes Martinez I, et al. In vitro activities of six new fluoroquinolones against Brucella melitensis. Antimicob. Agents Chemother. 1999; 43: 194-195.
75. Y.M. De Rautlin de la Roy, B. Grignon, G. Grollier, M.F. Coindreau, and B. Becq-Giraudon Rifampicin resistance in a strain of Brucella melitensis after treatment with doxycycline and rifampin J. Antimicrob. Chemother. 18 1986 648 649
76. M.W. Fountain, S.J. Weiss, A.G. Fountain, A. Shen, and R.P. Lenk Treatment of Brucella canis and Brucella abortus in vitro and in vivo by stable plurilamelar vesicle-encapsulated aminoglycosides J. Infect. Dis. 152 1985 529 535
77. G. Filice, G. Carnevale, P. Lanzarini, F. Castelli, G. Gorini, and R. Benzi-Cipelli Intracellular killing of Brucella melitensis within mouse peritoneal macrophages: influence of treatment with rifampin. An ultrastructural study Microbiologica 9 1986 189 198
78. M. Akova, D. Gür, D.M. Livermore, T. Kocagoz, and H.E. Akalin In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs Antimicrob. Agents Chemother. 43 1999 1298 1300
79. B. Shasha, R. Lang, and E. Rubinstein Therapy of experimental murine brucellosis with streptomycin, co-trimoxazole, ciprofloxacin, ofloxacin, pefloxacin, doxycycline, and rifampin Antimicrob. Agents Chemother. 36 1992 973 976
80. E.J. Young Brucella species (brucellosis) V.L. Yu R. Weber D. Raoult Antimicrobial therapy and vaccines 2002 Williams & Wilkins New York 121 140
81. J. Solera, E. Martinez-Alfaro, and A. Espinosa Recognition and optimum treatment of brucellosis Drugs 53 1997 245 256
82. J.M. Rolain, and M. Maurin Le traitement des brucelloses Antibiotiques. 2 2000 101 109
83. R. Lang, R. Dagan, I. Potasman, M. Einhorn, and R. Raz Failure of ceftriaxone in the treatment of acute brucellosis Clin. Infect. Dis. 14 1992 506 509
84. R. Lang, and E. Rubinstein Quinolones for the treatment of brucellosis J. Antimicrob. Chemother. 29 1992 357 363
85. G. Acocella, A. Bertrand, J. Baytout, J.B. Durrande, J.A. Garcia Rodriguez, and J. Kosmidis Comparison of three different regimens in the treatment of acute brucellosis: a multinational study J. Antimicrob. Chemother. 23 1989 433 439
86. J. Ariza, F. Gudiol, R. Pallares, P.F. Viladrich, G. Rufi, and J. Corredoira Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin Ann. Intern. Med. 117 1992 25 30
87. o. 289, Joint FAO/WHO Expert Committee on Brucellosis, 4th Report, Geneva, 1965.
88. th Report, Geneva, 1986.
89. J.D. Colmenero Castillo, S. Hernandez Marquez, J.M. Reguera Iglesias, F. Cabrera Franquelo, F. Rius Diaz, and A. Alonso Comparative trial of doxycycline plus streptomycin versus doxycycline plus rifampin for the therapy of human brucellosis Chemother. 35 1989 146 152
90. J.M. Montejo, I. Alberola, P. Glez-Zarate, A. Alvarez, J. Alonso, and A. Casanovas Open, randomized therapeutic trial of six antimicrobial regimens in the treatment of human brucellosis Clin. Infect. Dis. 16 1993 671 676
91. J. Solera, M. Rodriguez-Zapata, P. Geijo, J. Largo, J. Paulino, and L. Saez Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis Antimicrob. Agents Chemother. 39 1995 2061 2067
92. M.M. Lubani, K.I. Dudin, D.C. Sharda, D.S. Ndhar, G.F. Araj, and H.A. Hafez A multicenter therapeutic study of 1100 children with brucellosis Pediatr. Infect. Dis. 8 1989 75 78
93. M. Akova, D. Uzun, H.E. Akalin, M. Hayran, S. Unal, and D. Gur Quinolones in treatment of human brucellosis: comparative trial of ofloxacine-rifampin versus doxycycline-rifampin Antimicrob. Agents Chemother. 37 1993 1831 1834
94. C. Agalar, S. Usubutun, and R. Turkyilmaz Ciprofloxacin and rifampin versus doxycycline and rifampin in the treatment of brucellosis Eur. J. Clin. Microbiol. Infect. Dis. 18 1999 535 538
95. Y.A. Al-Eissa, A.M. Kambal, M.N. Al-Nasser, S.A. Al-Habib, I.M. Al-Fawaz, and F.A. Al-Zamil Childhood brucellosis: a study of 102 cases Pediatr. Infect. Dis. J. 9 1990 74 79
96. N.A. Khuri-Bulos, A.H. Daoud, and S.M. Azab Treatment of childhood brucellosis: results of a prospective trial on 113 children Pediatr. Infect. Dis. J. 12 1993 377 381
97. F. Jacobs, D. Abramowicz, P. Vereerstraeten, J.L. Le Clerc, F. Zech, and J.P. Thys Brucella endocarditis: the role of combined medical and surgical treatment Rev. Infect. Dis. 12 1990 740 744
98. N.B. McCullough Medical care following accidental injection of Brucella abortus, strain 19, in man J. Am. Vet. Med. Assoc. 143 1963 617 618
99. W.W. Spink, and H. Thompson Human brucellosis caused by Brucella abortus, strain 19 JAMA 153 1953 1162 1165
100. D. Pappagianis, S.S. Elberg, and D. Crouch Immunization against Brucella infection. Effects of graded doses of viable attenuated Brucella melitensis in humans Am. J. Epidemiol. 84 1966 21 25